-

Olfactive Biosolutions Hires COO; Enhances Senior Management Team

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Olfactive Biosolutions, the leader in adapting food molecules to treat chronic diseases, has hired David W. Allen, a long-time food industry executive, as its new Chief Operating Officer.

Mr. Allen joins Nils Lommerin, Olfactive’s President and CEO; along with Chris Hanson, Chief Technology Officer; Birgit Cameron, Chief Commercial Officer and John Mumaugh, Senior Vice President of Sales and Marketing on the company’s executive staff.

“We have built a world-class senior management team that is bringing our Pivit™ product to market early this year,” said Mr. Lommerin. “As we roll out our products for weight loss, lowering blood pressure and blood sugar, and alleviating other chronic conditions, Dave’s many years of experience in the food industry will be incredibly valuable to our young company as he synchronizes ingredient procurement, soft gel manufacturing, packaging and fulfilment partners to give our customers excellent service.”

Prior to joining Olfactive, Mr. Allen has overseen operations for a number of important companies, including Frito-Lay Corporation, Dell Computer and Del Monte Foods.

About Olfactive Biosolutions

Olfactive Biosolutions is the leader in harnessing food molecules to treat chronic diseases. It has developed world-leading receptor technology and expertise in both ectopic receptors in the gut, lungs, skin, heart, blood and elsewhere, and olfactory and taste receptors in the nose and tongue.

Its unique technology demonstrates how ectopic receptors often perform the same physiological tasks as active pharmaceutical ingredients or APIs, and what ligands activate or inhibit them.

To learn more, visit https://olfactive.bio or follow us on LinkedIn.

Contacts

Investor Contact:
Nils Lommerin
(949) 205-5776

Media Contact:
Deb Stapleton
(650) 815-1239
deb@olfactive.bio

Olfactive Biosolutions


Release Versions

Contacts

Investor Contact:
Nils Lommerin
(949) 205-5776

Media Contact:
Deb Stapleton
(650) 815-1239
deb@olfactive.bio

Social Media Profiles
More News From Olfactive Biosolutions

Olfactive Biosolutions Granted Second Patent to Repurpose Food Molecules for Treatment of Hypertension

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Olfactive Biosolutions, the leader in adapting food molecules to treat chronic diseases, was recently granted U.S. patent US 12,186,299 dated Jan. 7, 2025, Compositions And Methods For Treating Hypertension By Modulating Endocrine Activity, for its breakthrough food ingredient formulation that reduces high blood pressure. Pivit™ Blood Pressure can reduce blood pressure without the side effects and drawbacks of current pharmaceutical solutions, using food...

Olfactive Biosolutions Granted Third Dual GLP-1 / GIP Patent to Repurpose Food Molecules for Weight Management and Blood Sugar Regulation

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Olfactive Biosolutions, the leader in adapting food molecules to treat chronic diseases, was recently granted a third patent for inducing the secretion of GLP-1 and GIP, in U.S. patent US 12,171,727 B1 dated Dec. 24, 2024, Compositions and Methods for Treating Endocrine Diseases and Disorders. The patent specifically relates to oral formulations of natural food molecules for treating diabetes mellitus and obesity by modulating ectopic olfactory, taste and...

Olfactive Biosolutions Begins Production of Patented GLP-1/GIP Weight Loss and Blood Sugar Reduction Supplement

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Olfactive Biosolutions, the leader in harnessing food molecules for the treatment of chronic diseases, has begun production of its Protenx™ GLP-1/GIP Weight Loss patented weight loss and blood sugar reduction formulation under its U.S. patent US 12,102,664. Olfactive Biosolutions’ Protenx™ GLP-1/GIP Weight Loss breakthrough food ingredients formulation activates olfactory receptors in the gut to induce the dual secretion of natural GLP-1 and GIP to facili...
Back to Newsroom